Home > About us > Endorsing Organisations


Asian-Pacific Society of Interventional Cardiology (APSIC)

Asian-Pacific Society of Interventional Cardiology (APSIC)

The Asian-Pacific Society of Interventional Cardiology (APSIC) aims to promote interventional cardiology, particularly in the field of coronary intervention, in the Asian-Pacific area.

Founded initially by 11 eminent cardiologists who were convinced that the growth in interventional cardiology in the 21st century would be in Asia, the group had the vision to provide a forum in which Asia-Pacific experts could share knowledge and expertise in the field of catheter-based therapies, and to develop a joint academic research and education programme.
The society was formed during the third live demonstration course held in Singapore in July 1993, in the presence of 35 representatives from the region, and formally registered on 17 November 2000.

The APSIC comprise members from the Asian Pacific area and the diversity of the membership base is its key asset. A few members from each member nation/region are nominated or elected as Nation Representatives who reflect the views and opinions of members in their country. These representatives constitute the APSIC Advisory Board and meet at least 3-4 times every year.

The APSIC recently moved under the umbrella of the Asian-Pacific Society of Cardiology (APSC) and is now officially acknowledged as its interventional branch.


Scientific content endorsed by EAPCI, a registered branch of the European Society of Cardiology

European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EAPCI is a Registered Branch of the European Society of Cardiology (ESC). It was created in September 2006 as a result of a joint venture between the ESC Working Group on Interventional Cardiology and EuroPCR. EAPCI has over 3,100 members and 8 committees. Via its activities, it strives to become the exchange forum for all who care about cardiovascular health and wish to contribute to its improvement through the application of percutaneous cardiovascular interventions. The EAPCI is one of the initiators of SFL, along with EuroPCR.


PASCAR: Pan-African Society of Cardiology

Pan-African Society of Cardiology (PASCAR)

The Pan-African Society of Cardiology (PASCAR) had its beginnings in 1981 in Badagry, Nigeria.  PASCAR is an organisation of physicians from across Africa involved in prevention and treatment of cardiovascular disease and is concerned by the lack of progress in the diagnosis and effective treatment of cardiovascular disease across Africa.

Africa does offer some unique challenges but, with sound and achievable objectives and a long-term vision, a positive impact on the disease can be made. The PASCAR Governing Council focuses on identifying key issues, brainstorming novel solutions and designing appropriate programs to combat cardiovascular disease on the continent.

PASCAR forms working relationships with other organisations and departments in Africa with similar mandates and focuses. To understand the unique challenges faced in Africa, a core group of committed individuals with extraordinary knowledge of the African cardiovascular environment has been assembled in regional structures within a Governing Council.

In addition to our geographically aligned structures (North, East, South and West), PASCAR will establish Task Forces with representation from key role players in cardiovascular subspecialties such as interventional cardiology, life style risk modification, and allied catheterisation laboratory professionals.


PCR logo

PCR – Sharing knowledge, experience and practice in cardiovascular interventional medicine

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. Its activities cover a large spectrum, from the organisation of annual courses in Europe, Asia and the Middle East to editing a scientific journal, publishing textbooks as well as providing training sessions and online courses on thematic subjects.

The PCR Family ecosystem includes world-leading Course in interventional medicine like EuroPCR, AsiaPCR, Africa PCR, PCR London Valves to name a few, bringing together over 20,000 across the globe. The next edition of the Course will take place in Paris on 16-19 May 2017.

PCR is also actively involved in the community and support initiatives like Stent – Save a Life! and Share to name a few.

Find out more at www.pcronline.com

SOLACI - Sociedad Latinoamericana de cardiologia intervencionista

Latin American Society of Interventional Cardiology (SOLACI)

The Latin American Society of Interventional Cardiology (SOLACI) was created to advance and promote cardiovascular interventions in Latin America and the Caribbeans. Since 1993, SOLACI has strived for excellence through several strategies that include education and training, research promotion, guidelines development, regular meetings, regional sessions, and constant exchange between member countries.

Today, SOLACI represents Interventional cardiologists in 20 countries, has more than 2000 active members and strong alliances with the main interventional cardiology societies, both regional and international; among others, ESC (European Society of Cardiology), SCAI (Society for Cardiovascular Angiography and Interventions), ACC (American College of Cardiology), EAPCI ( European Association of Percutaneous Cardiovascular Interventions), CRF (Cardiovascular Research Foundation), and Sociedad Española de Cardiología (SEC).

In 2017, SOLACI joins the Stent-Save a Life, Global Initiative activities within Latin America and the Caribbeans to allow patients increased access to primary coronary angioplasty as a means to reduce mortality and morbidity after suffering from an Acute Coronary Syndrome, whilst continuing to facilitate patient awareness and education.


Stent - Save a Life!

The Stent – Save a Life! global initiative aims to improve the delivery of care and patient access to the life saving indications of primary percutaneous coronary intervention (p-PCI), thereby reducing mortality and morbidity in patients suffering from acute coronary syndromes (ACS).


Subscribe to our Newsletter today and stay up-to-date with the latest Stent – Save a Life! news :